Glaucoma Detection Software: AI Tools Every Optometrist Should Know in 2026

Hitarth, B. Tech Computer Science & Engineering

• July 13, 2026 • 1 min read • 2 views

Glaucoma Detection Software: AI Tools Every Optometrist Should Know in 2026

Glaucoma is the leading cause of irreversible blindness worldwide, and early detection is the only proven strategy for preventing vision loss. The challenge: glaucoma is often asymptomatic until significant optic nerve damage has already occurred. In 2026, AI-powered glaucoma detection software is giving optometrists the ability to identify structural and functional changes years earlier than traditional methods — changing the disease trajectory for millions of patients. This guide covers the most important AI glaucoma detection tools and how to integrate them into a practice.

The Clinical Gap AI Is Closing

Traditional glaucoma detection relies on the OD's subjective assessment of the optic nerve head (cup-to-disc ratio, rim tissue characteristics, disc hemorrhages) combined with automated visual field testing. Both have significant limitations: CDR estimation has wide inter-observer variability, and visual field loss only becomes detectable after 25-40% of retinal ganglion cells have already been lost. By the time a field defect is measurable, substantial irreversible damage has occurred.

AI-powered glaucoma detection addresses both limitations. Trained on millions of fundus photographs and OCT scans, AI models can detect subtle optic nerve structural features and RNFL thickness patterns that indicate early glaucomatous change — often before any visual field defect is measurable. This shifts detection into the pre-perimetric phase, when intervention can prevent significant vision loss.

Leading AI Glaucoma Detection Platforms in 2026

Zeiss FORUM with AI Glaucoma Module: Integrates with Zeiss OCT and fundus photography to provide AI-assisted trend analysis of RNFL thickness, GCC measurements, and optic disc parameters. The AI model identifies progression at the individual sector level, flagging change that may not reach the traditional global trend significance threshold. Particularly strong for long-term monitoring of established glaucoma suspects.

Heidelberg HEYEX with Trend Analysis AI: The Spectralis platform's HEYEX software includes AI-assisted event-based and trend-based progression analysis. Its follow-up mode for OCT ensures precise scan registration for longitudinal comparison — critical for detecting subtle RNFL progression. Research-grade reliability with a corresponding complexity of setup and interpretation.

Topcon AEYE Health (formerly EyeArt) Integration: AEYE Health's AI platform includes a glaucoma suspect detection module alongside its diabetic retinopathy screening capability. It analyzes non-mydriatic fundus photographs and returns a risk stratification score. Strong for population-level glaucoma screening workflows — particularly in primary care or diabetic eye exam programs.

IDx Glaucoma (Digital Diagnostics): Expanding beyond its flagship diabetic retinopathy product, Digital Diagnostics is developing an autonomous AI glaucoma detection module. Designed for use at the point of imaging without requiring a specialist to review every result — with OD review triggered only for positive or indeterminate findings.

Google DeepMind's ARDA integration with Moorfields: While not yet widely available in U.S. optometry practices, the DeepMind retinal AI has demonstrated ability to detect over 50 retinal diseases from OCT scans with specialist-level accuracy. Commercial deployment partnerships are expanding. Worth watching as a near-future capability.

Integrating AI Glaucoma Tools into Your Practice Workflow

The highest-value implementation of AI glaucoma detection follows a structured workflow:

Screening cohort identification: Use your EHR to identify all patients over 40, all African American patients (who have 3-4x higher glaucoma prevalence), all patients with a family history of glaucoma, and all high myopes — and flag them for enhanced imaging.
AI-assisted imaging review: Run all enhanced-imaging-flagged patients through your AI glaucoma analysis tool. The AI provides a risk score or flag that guides the OD's clinical assessment.
OD clinical correlation: The AI output informs but does not replace the OD's clinical judgment. Document both the AI result and your independent clinical assessment in the chart.
Structured follow-up: AI-flagged glaucoma suspects are scheduled for a structured monitoring protocol — typically OCT and visual field every 6-12 months — with AI trend analysis at each visit to detect progression.

Billing for AI-Assisted Glaucoma Detection

Fundus photography (92250) and OCT (92132/92133) used for glaucoma detection and monitoring are billable to medical insurance with appropriate diagnosis codes (H40 series). The AI analysis itself is currently incorporated into the service fee for these codes — there is no separate AI billing code in 2026. Document the AI output in your chart note as one component of your diagnostic assessment to support medical necessity for the imaging.

Frequently Asked Questions

Multiple peer-reviewed studies have demonstrated that leading AI glaucoma detection models match or exceed the sensitivity of non-specialist clinicians for identifying glaucomatous optic nerve changes from fundus photographs and OCT data. However, AI systems are not yet equivalent to subspecialty glaucoma specialists for complex case management. The current clinical consensus is that AI serves best as a decision-support tool that ensures no high-risk finding is missed, while the OD maintains clinical judgment for management decisions.

Pre-perimetric glaucoma is glaucomatous optic nerve and RNFL damage that has not yet caused a measurable visual field defect. It is detectable by OCT and AI-assisted structural analysis before any functional loss is measurable by standard perimetry. Detecting and treating glaucoma in the pre-perimetric stage — before field loss occurs — is the primary goal of modern glaucoma screening programs. AI tools make pre-perimetric detection practical at the practice level.

Priority screening populations include: all patients over 40 (universal risk at this age), African American patients of any age (3-4x higher prevalence), patients with a first-degree relative with glaucoma, patients with high myopia (>-6.00D), patients with ocular hypertension (IOP > 21 mmHg), and patients with thin central corneal thickness. Structuring your EHR to flag these risk factors automatically and link them to enhanced imaging protocols is the most efficient way to ensure no high-risk patient is missed.

AI glaucoma analysis tools are generally device-specific — Zeiss AI works with Zeiss OCT and fundus cameras, Heidelberg AI works with Spectralis, etc. Cross-device AI analysis tools exist (including cloud-based platforms that accept DICOM exports from any device) but are less common in routine practice. When investing in AI glaucoma detection, consider your existing imaging equipment and confirm compatibility with the AI platform you are evaluating.